FR3124397B1 - Dispositif destiné à la thérapie par injection de fluide - Google Patents

Dispositif destiné à la thérapie par injection de fluide Download PDF

Info

Publication number
FR3124397B1
FR3124397B1 FR2106751A FR2106751A FR3124397B1 FR 3124397 B1 FR3124397 B1 FR 3124397B1 FR 2106751 A FR2106751 A FR 2106751A FR 2106751 A FR2106751 A FR 2106751A FR 3124397 B1 FR3124397 B1 FR 3124397B1
Authority
FR
France
Prior art keywords
fluid
injection therapy
injection
fluid injection
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2106751A
Other languages
English (en)
Other versions
FR3124397A1 (fr
Inventor
Wooram Park
Shahid Naseer
Charlotte Pellet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR2106751A priority Critical patent/FR3124397B1/fr
Priority to PCT/JP2022/019473 priority patent/WO2022231011A1/fr
Publication of FR3124397A1 publication Critical patent/FR3124397A1/fr
Application granted granted Critical
Publication of FR3124397B1 publication Critical patent/FR3124397B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/003—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a lumen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0225—Carbon oxides, e.g. Carbon dioxide

Abstract

Dispositif destiné à la thérapie par injection de fluide La présente invention concerne un dispositif de thérapie par injection de fluide. Le dispositif comprend une unité d'injection comprenant un récipient pour fluide configuré pour stocker un fluide destiné à la thérapie par injection de fluide, une ou plusieurs aiguilles creuses, chaque aiguille creuse ayant un passage interne configuré pour acheminer le fluide du récipient pour fluide dans la peau et un filtre situé entre le récipient pour fluide et la ou les aiguilles creuses, le filtre étant configuré pour contrôler l'écoulement du fluide, et une unité de charge configurée pour être fixée de manière amovible à l'unité d'injection et acheminer le fluide à l'unité d'injection. Figure pour l'abrégé : [Fig 1A]
FR2106751A 2021-04-28 2021-06-24 Dispositif destiné à la thérapie par injection de fluide Active FR3124397B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR2106751A FR3124397B1 (fr) 2021-06-24 2021-06-24 Dispositif destiné à la thérapie par injection de fluide
PCT/JP2022/019473 WO2022231011A1 (fr) 2021-04-28 2022-04-22 Dispositif pour une thérapie par injection de fluide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2106751 2021-06-24
FR2106751A FR3124397B1 (fr) 2021-06-24 2021-06-24 Dispositif destiné à la thérapie par injection de fluide

Publications (2)

Publication Number Publication Date
FR3124397A1 FR3124397A1 (fr) 2022-12-30
FR3124397B1 true FR3124397B1 (fr) 2023-08-04

Family

ID=77821845

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2106751A Active FR3124397B1 (fr) 2021-04-28 2021-06-24 Dispositif destiné à la thérapie par injection de fluide

Country Status (1)

Country Link
FR (1) FR3124397B1 (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7967763B2 (en) * 2005-09-07 2011-06-28 Cabochon Aesthetics, Inc. Method for treating subcutaneous tissues
KR100690965B1 (ko) * 2006-06-07 2007-03-09 주식회사 메디스에스엘 카복시 테라피 장치
JP5845808B2 (ja) * 2011-10-28 2016-01-20 凸版印刷株式会社 マイクロニードルデバイスおよびその製造方法
WO2014142970A1 (fr) 2013-03-15 2014-09-18 Plum Systems Co. Appareil et procédé pour le rajeunissement tissulaire
WO2015005359A1 (fr) * 2013-07-08 2015-01-15 凸版印刷株式会社 Dispositif à corps creux de type aiguille
KR20190038271A (ko) * 2018-06-04 2019-04-08 티앤에이치바이오(주) 캡슐형 약물 주입 장치

Also Published As

Publication number Publication date
FR3124397A1 (fr) 2022-12-30

Similar Documents

Publication Publication Date Title
Fermand et al. Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications
US5951512A (en) Infusion port with modified drug reservoir
Seymour et al. 2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia
Burak Jr et al. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer
Cloud et al. Treatment strategies for dystonia
Tanabe et al. Role of descending noradrenergic system and spinal α2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse
Kirouac et al. GABAergic projection from the ventral tegmental area and substantia nigra to the periaqueductal gray region and the dorsal raphe nucleus
Pohle et al. Study of cutaneous lupus erythematosus: By immunohistochemical methods
Gabrielian et al. Substance P antagonists as a novel intervention for brain edema and raised intracranial pressure
FR3124397B1 (fr) Dispositif destiné à la thérapie par injection de fluide
RU2008116567A (ru) Биомаркеры
Dail et al. The hypogastric nerve pathway to penile erectile tissue: histochemical evidence supporting a vasodilator role
Al-Olama et al. The peptide AF-16 decreases high interstitial fluid pressure in solid tumors
DE602004019246D1 (de) Vorrichtung zum lagern und ausgeben einer fliesfähigen substanz
Pu et al. Dendritic morphologies of retinal ganglion cells projecting to the nucleus of the optic tract in the rabbit
Kaye et al. A method for assessing the accuracy of surgical technique in the correction of astigmatism.
Araki-Sasaki et al. The clinical characteristics of fungal keratitis in eyes after Descemet’s stripping and automated endothelial keratoplasty
Hayes et al. Rothia dentocariosa endophthalmitis following intravitreal injection—a case report
JP2022501608A (ja) 新型の便利な液体採取装置
ATE425255T1 (de) Antagonistische antikörper gegen ve-cadherin ohne negative effekte auf die vaskuläre permeabilität
FR2870130A1 (fr) Dispositif medical implantable et suturable en sous-cutane
FR3117039B1 (fr) Ensemble pour prélèvement et injection intra-articulaire
US20180264202A1 (en) Injection Device and Methods Related Thereto
Philp Denton, Miss Kerrie Elizabeth (b. 22/12/1952)
Ormerod Immunological concepts and the eye: a review of the classical and ocular Arthus reactions

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20221230

PLFP Fee payment

Year of fee payment: 3